Refine
Has Fulltext
- yes (31)
Is part of the Bibliography
- yes (31)
Document Type
- Journal article (26)
- Preprint (4)
- Doctoral Thesis (1)
Keywords
- boron (4)
- multiple myeloma (4)
- diborenes (3)
- 18F-FDG PET/CT (2)
- Diborene (2)
- mechanical thrombectomy (2)
- norepinephrine (2)
- relapse (2)
- structure elucidation (2)
- (cardiac) surgery (1)
- 11C-Methionine PET/CT (1)
- 3D cell culture (1)
- 3D printing (1)
- 68Ga-Pentixafor PET/CT (1)
- ARF (1)
- Boranes (1)
- Borylene (1)
- CD274 (1)
- CD38 (1)
- Conjugation (1)
- DFT (1)
- Diboren (1)
- Hauptgruppenelementchemie (1)
- Hauptgruppenelementverbindungen (1)
- Health care service research (1)
- Hydroborierung (1)
- JAK2 (1)
- Kation (1)
- Konjugation (1)
- Lewis acids (1)
- MOR202 (1)
- MTB (1)
- MUST-Score (1)
- Main Group Chemistry (1)
- Melanoma (1)
- Metastatic breast cancer (1)
- N-heterocyclic carbenes (1)
- NAKO (1)
- NMJ–neuromuscular junction (1)
- PD-L1 (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Photoisomerisierung (1)
- TP53 (1)
- Triboran (1)
- acetone (1)
- acute kidney injury (1)
- adult neurogenesis (1)
- adult-onset (1)
- aromaticity (1)
- artificial intelligence (1)
- autoimmune (1)
- biomarker (1)
- bone remineralization (1)
- boron chains (1)
- boronium cations (1)
- borylene complexes (1)
- borylenes (1)
- brain development (1)
- brain endothelium (1)
- cancer care (1)
- carbenes (1)
- catecholamines (1)
- cations (1)
- cerebral ischemia (1)
- clinical studies (1)
- collateral circulation (1)
- computed tomography (1)
- conjugation (1)
- cycloaddition (1)
- daratumumab (1)
- delivery mode (1)
- density-functional calculations (1)
- diboranes (1)
- diboron (1)
- diborynes (1)
- dopamine (1)
- electrophiles (1)
- endoglin (1)
- endoscopic instruments (1)
- endoscopic intervention (1)
- endoscopy (1)
- fused thiazaboroles (1)
- genetic polymorphisms (1)
- hippocampus (1)
- humans (1)
- hydroboration (1)
- hypoxia (1)
- iPSC (induced pluripotent stem cells) (1)
- iminoboranes (1)
- inflammatory cytokines (1)
- inorganic chemistry (1)
- ischemic stroke (1)
- large vessel occlusion (1)
- late-onset (1)
- leukocytes (1)
- m-Health (1)
- malnutrition (1)
- metathesis (1)
- minimally invasive surgery (1)
- monocyte subset (1)
- motoneuron (MN) (1)
- natural language processing (1)
- neurogenesis (1)
- neutrophils (1)
- noradrenaline (1)
- nutritional counseling (1)
- nutritional medical needs (1)
- nutritional risk screening (1)
- offspring (1)
- olfactory bulb neurogenesis (1)
- oncology (1)
- oncology outpatients (1)
- ontology (1)
- outcomes research (1)
- outreach (1)
- p53 (1)
- patient access (1)
- pattern (1)
- perinatal (1)
- peripheral artery occlusive disease (1)
- photoisomerization (1)
- pi-conjugation (1)
- precision oncology (1)
- progression (1)
- radiogenomics (1)
- rapid prototyping (1)
- reaction mechanisms (1)
- reactive intermediates (1)
- real world data (1)
- real world evidence (1)
- rearrangements (1)
- reduction (1)
- reductive coupling (1)
- refractory (1)
- reperfusion injury (1)
- risk factors (1)
- risk prediction (1)
- sex (1)
- shedding (1)
- skeletal muscle (1)
- small-molecule activation (1)
- smoldering myeloma (1)
- stroke (1)
- subventricular zone (1)
- triboranes (1)
- ventricular zone (1)
- whole-body imaging (1)
Institute
- Institut für Anorganische Chemie (11)
- Medizinische Klinik und Poliklinik II (9)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (4)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Klinik und Poliklinik für Nuklearmedizin (3)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (2)
- Neurologische Klinik und Poliklinik (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Comprehensive Cancer Center Mainfranken (1)
Sonstige beteiligte Institutionen
Utilizing 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT), we performed this pilot study to evaluate the link between cytogenetic/genomic markers and imaging patterns in relapsed/refractory (RR) multiple myeloma (MM). We retrospectively analyzed data of 24 patients with RRMM who were treated at our institution between November 2018 and February 2020. At the last relapse/progression, patients had been treated with a median of three (range 1–10) lines of therapy. Six (25%) patients showed FDG avid extramedullary disease without adjacency to bone. We observed significantly higher maximum standardized uptake values (SUV\(_{max}\)) in patients harboring del(17p) compared with those without del(17p) (p = 0.025). Moreover, a high SUV\(_{max}\) of >15 indicated significantly shortened progression-free survival (PFS) (p = 0.01) and overall survival (OS) (p = 0.0002). One female patient exhibited biallelic TP53 alteration, i.e., deletion and mutation, in whom an extremely high SUV\(_{max}\) of 37.88 was observed. In summary, this pilot study suggested a link between del(17p)/TP53 alteration and high SUV\(_{max}\) on 18F-FDG PET/CT in RRMM patients. Further investigations are highly warranted at this point.